https://www.wboc.com/story/44455573/pulmonary-arterial-hypertension-pipeline-research-report-2021-researchandmarketscom
Pulmonary Arterial Hypertension Pipeline Research Report 2021 - ResearchAndMarkets.com
Key Players
- Merck Sharp & Dohme
- Acceleron Pharma
- Liquidia Technologies
- Gossamer Bio
- Resverlogix
- PhaseBio Pharmaceuticals
- Pharmosa BioPharm
- Complexa
- Gmax Biopharm Australia
- Mezzion
- Radikal Therapeutics
- Galectin Therapeutics
- Altavant Sciences
- Ribomic
Key Products
- MK-5475
- Sotatercept
- LIQ861
- GB-002
- Apabetalone
- PB1046
- L-606
- CXA-10
- GMA-301
- Udenafil
- R107
- Belapectin
- Rodatristat ethyl
- RBM-011
For more information about this clinical trials report visit https://www.researchandmarkets.com/r/unf97v